Related Experiment Video

Updated: Jan 16, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.3K

Seroconversion after autogenous vaccination against mastitis in crossbred dairy cows

Ana Cláudia Fagundes Faria1, Carla Cristian Campos2, Paulo César Franco Dutra3

  • 1Faculty of Veterinary Medicine (FAMEV), Federal University of Uberlândia (UFU), Km 78 BR 050 Highway, Campus Glória, Uberlândia, Minas Gerais, 38410-337, Brazil.

Tropical Animal Health and Production
|September 30, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Adaptative immunityAutogenous vaccineDairy cowsMastitis

More Related Videos

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.7K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
32.8K
Vaccinations01:51

Vaccinations

Overview
51.3K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
790